Enzo Biochem Inc. ($0.01 Par Value) (ENZ)

Name: Enzo Biochem Inc. ($0.01 Par Value) (ENZ) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Enzo Biochem Inc. ($0.01 Par Value) (ENZ)

Stock Card

$0.54

$0.00 (-0.02%)

As on 18-Jun-2025 09:30EDT

Market cap

$16 Mln

Revenue (TTM)

$27 Mln

P/E Ratio

P/B Ratio

0.7

Div. Yield

125 %

Enzo Biochem Inc. ($0.01 Par Value) (ENZ) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.51 High: 0.54

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.1 %
ROCE

-- %
Industry P/E

33.74
EV/EBITDA

-3.3
Debt to Equity

0
Book Value

$--
EPS

$--
Face value

--
Shares outstanding

52,402,800

10 Years Aggregate

CFO

$-20.76 Mln

EBITDA

$370.27 Mln

Net Profit

$-111.34 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)	-24.4	-3.1	14.8	-51.4	-37.3	-24.3	-15.9
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 18-Jun-2025 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2024	2023	2022	2021	2020	2019	2018
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)	-48.3	-2.8	-55.5	27.4	-4.2	-5.4	-65.7
S&P Small-Cap 600	7.0	13.9	-17.4	25.3	9.6	20.9	-9.7
BSE Sensex	8.1	18.7	4.4	22.0	15.8	14.4	5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Enzo Biochem Inc. ($0.01 Par Value) (ENZ)

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays,... biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York. Read more

Chief Executive Officer

Ms. Kara Cannon
CEO & Director

Ms. Kara Cannon
Headquarters

Farmingdale, NY
Website

https://www.enzo.com

FAQs for Enzo Biochem Inc. ($0.01 Par Value) (ENZ)

What is the current share price of Enzo Biochem Inc ($001 Par Value) (ENZ) Today?

The share price of Enzo Biochem Inc ($001 Par Value) (ENZ) is $0.54 (NYSE) as of 18-Jun-2025 09:30 EDT. Enzo Biochem Inc ($001 Par Value) (ENZ) has given a return of -37.3% in the last 3 years.

What is the current PB & PE ratio of Enzo Biochem Inc ($001 Par Value) (ENZ)?

Since, TTM earnings of Enzo Biochem Inc ($001 Par Value) (ENZ) is negative, P/E ratio is not available.
The P/B ratio of Enzo Biochem Inc ($001 Par Value) (ENZ) is 0.65 times as on 18-Jun-2025, a 82 discount to its peers’ median range of 3.54 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2024	--	--
2023	--	--
2022	--	--
2021	--	--
2020	--	--

What is the 52 Week High and Low of Enzo Biochem Inc ($001 Par Value) (ENZ)?

The 52-week high and low of Enzo Biochem Inc ($001 Par Value) (ENZ) are Rs -- and Rs -- as of 28-Aug-2026.

What is the market cap of Enzo Biochem Inc ($001 Par Value) (ENZ)?

Enzo Biochem Inc ($001 Par Value) (ENZ) has a market capitalisation of $ 16 Mln as on 18-Jun-2025. As per SEBI classification, it is a Small Cap company.

Should I invest in Enzo Biochem Inc ($001 Par Value) (ENZ)?

Before investing in Enzo Biochem Inc ($001 Par Value) (ENZ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.